Dishman Carbogen Amcis, a prominent player in the pharmaceutical and biotechnology sectors, is headquartered in India. Founded in 1983, the company has established itself as a leader in contract research and manufacturing services, with a strong presence in Europe, North America, and Asia. Specialising in custom synthesis, active pharmaceutical ingredients (APIs), and drug development services, Dishman Carbogen Amcis is recognised for its innovative approach and commitment to quality. The company’s state-of-the-art facilities and expertise in complex chemistry set it apart in a competitive market. With a focus on sustainability and regulatory compliance, Dishman Carbogen Amcis has achieved significant milestones, including successful collaborations with major pharmaceutical companies. Its dedication to excellence has solidified its position as a trusted partner in the global pharmaceutical landscape.
How does Dishman Carbogen Amcis's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Dishman Carbogen Amcis's score of 26 is lower than 58% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Dishman Carbogen Amcis reported total carbon emissions of approximately 58,157,000 kg CO2e for Scope 1 and about 17,725,920 kg CO2e for Scope 2. This marks a decrease from 2023, where emissions were approximately 68,113,600 kg CO2e for Scope 1 and about 15,700,600 kg CO2e for Scope 2. The company has disclosed emissions data for both Scope 1 and Scope 2 but has not reported any Scope 3 emissions. Despite the significant emissions figures, there are currently no specific reduction targets or climate pledges outlined by Dishman Carbogen Amcis. The data reported is cascaded from the parent company, Dishman Carbogen Amcis Limited, indicating a corporate family relationship that influences their emissions reporting. The company’s emissions intensity metrics indicate a total Scope 1 and Scope 2 emission intensity of approximately 5.73 kg CO2e per rupee of turnover adjusted for Purchasing Power Parity (PPP) in 2024, and 4.90 kg CO2e per rupee in 2023. In terms of physical output, the emissions intensity was about 88.0 kg CO2e per tonne in 2024, down from 62.0 kg CO2e per tonne in 2023. Overall, while Dishman Carbogen Amcis has made strides in reducing its emissions year-on-year, the absence of formal reduction targets suggests an opportunity for further commitment to climate action.
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 48,975,800 | 00,000,000 | 00,000,000 |
| Scope 2 | 17,489,600 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Dishman Carbogen Amcis has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
